Two-year outcomes of intravitreal bevacizumab therapy for macular oedema secondary to branch retinal vein occlusion.
about
Clinical Trials in Branch Retinal Vein OcclusionPharmacotherapy for treatment of retinal vein occlusion.Subthreshold grid laser versus intravitreal bevacizumab as second-line therapy for macular edema in branch retinal vein occlusion recurring after conventional grid laser treatment.One-year outcome of bevacizumab therapy for chronic macular edema in central and branch retinal vein occlusions in real-world clinical practice in the UK.Comparison of the Efficacy of Intravitreal Aflibercept and Bevacizumab for Macular Edema Secondary to Branch Retinal Vein Occlusion.Combination therapy of intravitreal bevacizumab with single simultaneous posterior subtenon triamcinolone acetonide for macular edema due to branch retinal vein occlusion.New Developments in the Classification, Pathogenesis, Risk Factors, Natural History, and Treatment of Branch Retinal Vein OcclusionThe outcome of low-frequency intravitreal bevacizumab therapy for macular edema in retinal vein occlusions.Effects of two different doses of intravitreal bevacizumab on subfoveal choroidal thickness and retinal vessel diameter in branch retinal vein occlusion.Outcome of "treat and monitor" regimen of aflibercept and ranibizumab in macular edema secondary to non-ischemic branch retinal vein occlusion.Macular cystic changes as predictive factor for the recurrence of macular oedema in branch retinal vein occlusion.Intravitreal Injection of Anti-vascular Endothelial Growth Factor Agents for Ocular Vascular Diseases: Clinical Practice Guideline.
P2860
Q26767092-CFF3E8CB-26B4-4F9E-891D-54561CEA409FQ35238943-7B06383E-5B4C-4D67-8410-55C03BC6AEC4Q35405601-EE10F9DD-2096-43A1-965E-08792BE204D0Q36111710-4DE3965A-7BCB-4CB0-8651-942CC59053CAQ36835209-8EBEC632-9032-45B7-91A1-9353BB32B657Q38414123-40016CA0-38F5-4772-AA16-435634C16CE7Q38848800-A6649C7C-8F26-4A6A-971F-1B8BEC186516Q40089995-6501B677-2F56-403D-A2ED-CC0303AE0007Q42412682-766756B2-A4E1-46AE-BF76-393EE56D00D1Q48352897-2C2A10C4-A58B-4A03-BEA0-D6E50EBF3B54Q50859000-0E76F375-2B61-4809-868C-E629541CD362Q54942391-FFFF1496-A383-4E3F-9E2F-5E19E07FC008
P2860
Two-year outcomes of intravitreal bevacizumab therapy for macular oedema secondary to branch retinal vein occlusion.
description
2013 nî lūn-bûn
@nan
2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Two-year outcomes of intravitr ...... branch retinal vein occlusion.
@ast
Two-year outcomes of intravitr ...... branch retinal vein occlusion.
@en
type
label
Two-year outcomes of intravitr ...... branch retinal vein occlusion.
@ast
Two-year outcomes of intravitr ...... branch retinal vein occlusion.
@en
prefLabel
Two-year outcomes of intravitr ...... branch retinal vein occlusion.
@ast
Two-year outcomes of intravitr ...... branch retinal vein occlusion.
@en
P2093
P2860
P1476
Two-year outcomes of intravitr ...... branch retinal vein occlusion.
@en
P2093
Hideo Ohtsuka
Hirokuni Kitamei
Kimitaka Takami
Makoto Higuchi
Reiko Matsushita
Shoko Kosaka
Shoko Shioya
Taiichi Hikichi
Takuro Matsushita
P2860
P304
P356
10.1136/BJOPHTHALMOL-2013-303121
P407
P577
2013-11-08T00:00:00Z